Cargando…

Conditional Survival of female patients with operable invasive Breast Cancer in US: A population-based study

Background: Conditional survival (CS) is used to describe the dynamic possibility of survival, considering the changes of death risk with time lapsing. This study aimed to estimate the conditional disease-specific survival (CDS) for the female with operable invasive breast cancer. Methods: The data...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ai, Bolun, Wang, Xiangyu, Kong, Xiangyi, Wang, Zhongzhao, Fang, Yi, Wang, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477435/ https://www.ncbi.nlm.nih.gov/pubmed/32913471 http://dx.doi.org/10.7150/jca.46183

Ejemplares similares

Research Progresses in Immunological Checkpoint Inhibitors for Breast Cancer Immunotherapy
por: Zhang, Wenxiang, et al.
Publicado: (2021)

NCCBM, a Nomogram Prognostic Model in Breast Cancer Patients With Brain Metastasis
por: Liu, Qiang, et al.
Publicado: (2021)

LINC01355 suppresses breast cancer growth through FOXO3-mediated transcriptional repression of CCND1
por: Ai, Bolun, et al.
Publicado: (2019)

Comparisons of Therapeutic and Aesthetic Effects of One-Stage Implant-Based Breast Reconstruction with and without Biological Matrix
por: Gao, Peng, et al.
Publicado: (2020)

Subsequent risk of suicide among 9,300,812 cancer survivors in US: A population-based cohort study covering 40 years of data
por: Liu, Qiang, et al.
Publicado: (2022)

Pretreatment Systemic Inflammation Response Index in Patients with Breast Cancer Treated with Neoadjuvant Chemotherapy as a Useful Prognostic Indicator
por: Chen, Li, et al.
Publicado: (2020)

Pre‐treatment systemic immune‐inflammation index is a useful prognostic indicator in patients with breast cancer undergoing neoadjuvant chemotherapy
por: Chen, Li, et al.
Publicado: (2020)

Nutritional Risk Index Predicts Survival in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy
por: Chen, Li, et al.
Publicado: (2022)

Comprehensive Analysis of the Expressionand Prognosis for TDO2 in Breast Cancer
por: Liu, Qiang, et al.
Publicado: (2020)

A Systematic Study on Zinc-Related Metabolism in Breast Cancer
por: Qu, Zheng, et al.
Publicado: (2023)

Prognostic Value and Clinical Significance of LIPH in Breast Cancer
por: Gao, Peng, et al.
Publicado: (2021)

Molecular and Clinical Characterization of LAG3 in Breast Cancer Through 2994 Samples
por: Liu, Qiang, et al.
Publicado: (2021)

Prognostic Nutritional Index (PNI) in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy as a Useful Prognostic Indicator
por: Chen, Li, et al.
Publicado: (2021)

Molecular and Clinical Characterization of PD-1 in Breast Cancer Using Large-Scale Transcriptome Data
por: Liu, Qiang, et al.
Publicado: (2020)

Identification of the Significant Genes Regulated by Estrogen Receptor in Estrogen Receptor-Positive Breast Cancer and Their Expression Pattern Changes When Tamoxifen or Fulvestrant Resistance Occurs
por: Cheng, Ran, et al.
Publicado: (2020)

The Systemic Immune-Inflammation Index is an Independent Predictor of Survival in Breast Cancer Patients
por: Zhu, Mengliu, et al.
Publicado: (2022)

Recent advances of transcriptomics and proteomics in triple‐negative breast cancer prognosis assessment
por: Li, Yuan, et al.
Publicado: (2022)

Efficacy and Safety of Anti-PD-1/ PD-L1 Monotherapy for Metastatic Breast Cancer: Clinical Evidence
por: Qi, Yihang, et al.
Publicado: (2021)

The Systemic Inflammation Response Index as an Independent Predictor of Survival in Breast Cancer Patients: A Retrospective Study
por: Zhu, Mengliu, et al.
Publicado: (2022)

Prolactin and endocrine therapy resistance in breast cancer: The next potential hope for breast cancer treatment
por: Li, Yuan, et al.
Publicado: (2021)

PD-1/PD-L1 Inhibitor-Associated Myocarditis: Epidemiology, Characteristics, Diagnosis, Treatment, and Potential Mechanism
por: Dong, Hao, et al.
Publicado: (2022)

Oncotype DX Breast Recurrence Score Distribution and Chemotherapy Benefit Among Women of Different Age Groups With HR-Positive, HER2-Negative, Node-Negative Breast Cancer in the SEER Database
por: Cheng, Ran, et al.
Publicado: (2020)

The Causal Effect of Dietary Composition on the Risk of Breast Cancer: A Mendelian Randomization Study
por: Dong, Hao, et al.
Publicado: (2023)

Omitting ALND Is Not Safe for a Cohort of Early-Stage Breast Cancer Patients with 1–2 SLNs Macro-Metastases and Breast-Conserving Therapy: A Single-Center Retrospective Study
por: WANG, Xiangyu, et al.
Publicado: (2020)

Expression signatures and roles of microRNAs in inflammatory breast cancer
por: Qi, Yihang, et al.
Publicado: (2019)

The Prognostic Significance of Anisomycin-Activated Phospho-c-Jun NH2-Terminal Kinase (p-JNK) in Predicting Breast Cancer Patients’ Survival Time
por: Chen, Li, et al.
Publicado: (2021)

AGR2: a secreted protein worthy of attention in diagnosis and treatment of breast cancer
por: Zhang, Ke, et al.
Publicado: (2023)

A meta-analysis: Is there any association between MiR-608 rs4919510 polymorphism and breast cancer risks?
por: Wang, Jing, et al.
Publicado: (2017)

Primary Giant Cell Tumor of the Breast With Pulmonary Metastasis: A Case Report and Review of the Literature
por: Zhang, Wenxiang, et al.
Publicado: (2021)

PD-1/PD-L1 Inhibitors in Patients With Preexisting Autoimmune Diseases
por: Zhang, Ke, et al.
Publicado: (2022)

Molecular and Clinical Characterization of CCT2 Expression and Prognosis via Large-Scale Transcriptome Profile of Breast Cancer
por: Liu, Qiang, et al.
Publicado: (2021)

Controlling Nutritional Status (CONUT) as a Novel Postoperative Prognostic Marker in Breast Cancer Patients: A Retrospective Study
por: Zhu, Mengliu, et al.
Publicado: (2022)

Prognostic Influence of Preoperative Mammographic Breast Density in Operable Invasive Female Breast Cancer
por: Hwang, Ki-Tae, et al.
Publicado: (2018)

PD-L1 Protein Expression Is Associated With Good Clinical Outcomes and Nomogram for Prediction of Disease Free Survival and Overall Survival in Breast Cancer Patients Received Neoadjuvant Chemotherapy
por: Chen, Li, et al.
Publicado: (2022)

Better survival in PMRT of female breast cancer patients with >5 negative lymph nodes: A population-based study
por: Wang, Haiyong, et al.
Publicado: (2017)

Recent Advances in the Role of Discoidin Domain Receptor Tyrosine Kinase 1 and Discoidin Domain Receptor Tyrosine Kinase 2 in Breast and Ovarian Cancer
por: Chen, Li, et al.
Publicado: (2021)

Mechanism of trastuzumab resistance caused by HER-2 mutation in breast carcinomas
por: Kong, Xiangyi, et al.
Publicado: (2019)

Hormone-receptor expression and survival patterns in operated cases of female invasive ductal breast carcinoma in Kerala: a retrospective cohort study
por: Vettuparambil, Ajith, et al.
Publicado: (2015)

The Research Progress on the Prognostic Value of the Common Hematological Parameters in Peripheral Venous Blood in Breast Cancer
por: Chen, Li, et al.
Publicado: (2020)

Comparison of adjuvant ED and EC-D regimens in operable breast invasive ductal carcinoma
por: Jiang, Liyu, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_16jp8831i1tfch48ug5q6s7456